Stericycle (NASDAQ:SRCL) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Stericycle (NASDAQ:SRCL) in a research report released on Saturday morning. The brokerage issued a hold rating on the business services provider’s stock.

Stericycle Price Performance

NASDAQ:SRCL opened at $60.86 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.13 and a current ratio of 1.13. The firm has a market cap of $5.65 billion, a price-to-earnings ratio of 160.16, a P/E/G ratio of 3.32 and a beta of 1.11. Stericycle has a 52 week low of $37.78 and a 52 week high of $61.77. The firm’s 50-day simple moving average is $60.35 and its 200 day simple moving average is $56.06.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.04. The firm had revenue of $661.60 million for the quarter, compared to analyst estimates of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. As a group, sell-side analysts predict that Stericycle will post 2.29 earnings per share for the current year.

Hedge Funds Weigh In On Stericycle

Several hedge funds and other institutional investors have recently modified their holdings of SRCL. Vanguard Group Inc. lifted its holdings in shares of Stericycle by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 8,969,118 shares of the business services provider’s stock worth $444,509,000 after acquiring an additional 52,576 shares during the last quarter. Capital Research Global Investors grew its position in Stericycle by 11.4% during the 1st quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock worth $351,732,000 after acquiring an additional 679,974 shares during the last quarter. Earnest Partners LLC increased its holdings in Stericycle by 12.4% in the 1st quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock worth $129,766,000 after purchasing an additional 271,025 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Stericycle by 7.0% in the second quarter. Dimensional Fund Advisors LP now owns 2,171,659 shares of the business services provider’s stock valued at $126,238,000 after purchasing an additional 142,814 shares during the last quarter. Finally, Pentwater Capital Management LP acquired a new stake in shares of Stericycle during the second quarter valued at about $83,010,000. Institutional investors own 98.82% of the company’s stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.